Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors.
Coya TapiaPhyu P AungSinchita Roy-ChowdhuriMingxuan XuFengying OuyangAnas AlshawaJoud HajjarGopal SinghVincent YangLilibeth CastilloHung LeRavi MurthyBettzy StephenKenneth R HessIgnacio WistubaAung NaingPublished in: Journal for immunotherapy of cancer (2021)
NCT02721732.